TMEM9 activators are a class of chemical compounds that specifically target and increase the activity of the transmembrane protein 9 (TMEM9). TMEM9 is a protein that resides within the cellular membrane and is believed to play a role in various cellular processes, including the regulation of ion channels and transporters, as well as the modulation of intracellular signaling pathways. The unique feature of activators in this class is their ability to interact with TMEM9, enhancing its natural function within the cell. These interactions may influence the protein's structural conformation, stability, or its interaction with other cellular components, thereby augmenting its activity. The chemical structures of TMEM9 activators can be diverse, ranging from small organic molecules to larger biomolecules, all designed or discovered based on their capacity to engage with TMEM9 in a way that promotes its functional role.
The exploration and identification of TMEM9 activators involve a combination of biochemical, genetic, and computational techniques to understand and manipulate the interaction between these compounds and the TMEM9 protein. High-throughput screening of chemical libraries can reveal potential activators, which are then subjected to further analysis to confirm and characterize their mode of action. Studies into the structure-activity relationship (SAR) of these compounds provide insights into which chemical moieties are essential for the activation of TMEM9. In addition to direct binding assays, techniques such as molecular docking and dynamic simulation are used to predict how these activators interact with TMEM9 at an atomic level. The elucidation of the three-dimensional structure of TMEM9 and its complex with activators is critical, as it allows for the refinement of activator design to achieve higher specificity and potency. Moreover, understanding the precise mechanism by which these activators enhance TMEM9 function requires detailed kinetic and biophysical studies, which can reveal the impact of activator binding on the protein's conformation and activity within the cellular membrane environment.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
As an inhibitor of vacuolar-type H+-ATPase, it may upregulate TMEM9 expression to compensate for disrupted vesicle acidification. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
A sodium ionophore that disrupts lysosomal acidification, potentially increasing TMEM9 expression as a compensatory response. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Induces ER stress, which could lead to an increase in TMEM9 expression due to the heightened need for vesicular trafficking. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A known ER stressor that could enhance TMEM9 expression to manage increased demands on the secretory pathway. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Increases intracellular cAMP, which may enhance TMEM9 expression as part of the signaling pathways involved in vesicle dynamics. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Known to raise the pH of intracellular vesicles and might induce TMEM9 expression to restore normal vesicle acidification. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
Inhibits cysteine proteases and could lead to the upregulation of TMEM9 in response to altered proteolytic activity in vesicles. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that may increase TMEM9 expression due to the accumulation of proteins requiring vesicular transport for degradation. | ||||||
Concanamycin A | 80890-47-7 | sc-202111 sc-202111A sc-202111B sc-202111C | 50 µg 200 µg 1 mg 5 mg | $66.00 $167.00 $673.00 $2601.00 | 109 | |
Another V-ATPase inhibitor that might induce TMEM9 expression to counteract impaired vesicular acidification. | ||||||
Nigericin sodium salt | 28643-80-3 | sc-201518A sc-201518 sc-201518B sc-201518C sc-201518D | 1 mg 5 mg 25 mg 1 g 5 g | $46.00 $112.00 $240.00 $7079.00 $27417.00 | 9 | |
As an ionophore that alters membrane potential, it could influence TMEM9 expression to maintain vesicle function. | ||||||